<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Statistics | CSE Tracker</title>
    <link>https://master--youthful-lamport-190a0e.netlify.app/category/20210517statistics/</link>
      <atom:link href="https://master--youthful-lamport-190a0e.netlify.app/category/20210517statistics/index.xml" rel="self" type="application/rss+xml" />
    <description>Statistics</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><lastBuildDate>Mon, 17 May 2021 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://master--youthful-lamport-190a0e.netlify.app/images/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_512x512_fill_lanczos_center_2.png</url>
      <title>Statistics</title>
      <link>https://master--youthful-lamport-190a0e.netlify.app/category/20210517statistics/</link>
    </image>
    
    <item>
      <title>The Statistical Methods in Imaging Conference 2021</title>
      <link>https://master--youthful-lamport-190a0e.netlify.app/conference/20210517the-statistical-methods-in-imaging-conference-2021/</link>
      <pubDate>Mon, 17 May 2021 00:00:00 +0000</pubDate>
      <guid>https://master--youthful-lamport-190a0e.netlify.app/conference/20210517the-statistical-methods-in-imaging-conference-2021/</guid>
      <description>&lt;p&gt;&lt;span style=&#34;color: salmon;&#34;&gt;&lt;em&gt;Registration ends on May 2, 2021&lt;/em&gt;&lt;/span&gt;&lt;/p&gt;</description>
    </item>
    
    <item>
      <title>Designing a Randomized Trial with Sample Size Re-estimation - Challenges and Best Practices</title>
      <link>https://master--youthful-lamport-190a0e.netlify.app/webinar/20210325designing-a-randomized-trial-with-sample-size-re-estimation-challenges-and-best-practices/</link>
      <pubDate>Thu, 25 Mar 2021 09:00:00 -0800</pubDate>
      <guid>https://master--youthful-lamport-190a0e.netlify.app/webinar/20210325designing-a-randomized-trial-with-sample-size-re-estimation-challenges-and-best-practices/</guid>
      <description>&lt;p&gt;In this webinar, we will play the part of a sponsor consulting a statistician with the goal of designing a randomized trial with sample-size re-estimation. We will discuss the concept of conditional power and the promising-zone method, and we will present a pragmatic view of some issues, including when to plan the sample-size re-estimation in the course of the accrual, how to select the amount of sample-size increase, and how to operate such trials in practice. We will also discuss the pros- and cons- of using this type of design in relation to the clinical setting in which the trial is designed and endpoints it uses. Moreover, we will discuss the regulators’ views and illustrate our discussion with practical examples.&lt;/p&gt;</description>
    </item>
    
    <item>
      <title>Identification of Putative Causal Loci in Whole-Genome Sequencing Data via Knockoff Statistics</title>
      <link>https://master--youthful-lamport-190a0e.netlify.app/webinar/20210312identification-of-putative-causal-loci-in-whole-genome-sequencing-data-via-knockoff-statistics/</link>
      <pubDate>Fri, 12 Mar 2021 16:00:00 -0800</pubDate>
      <guid>https://master--youthful-lamport-190a0e.netlify.app/webinar/20210312identification-of-putative-causal-loci-in-whole-genome-sequencing-data-via-knockoff-statistics/</guid>
      <description>&lt;p&gt;The analysis of whole-genome sequencing studies is challenging due to the large number of rare variants in noncoding regions and the lack of natural units for testing. Existing association tests often suffer from insufficient power due to the substantially increased burden of multiple testing and correspondingly stringent multiple testing corrections that do not appropriately account for correlations. Using population-level whole-genome sequencing data, we propose a new statistical method to detect and localize rare and common risk variants based on a recently developed knockoff framework. The proposed approach includes a novel sequential knockoff generator for both rare and common variants in whole-genome sequencing studies, paired with a powerful screening method to comprehensively analyze rare and common variants across the genome. The proposed knockoff generator is scalable to large whole-genome sequencing datasets, and the screening method is powerful in detecting signals across the genome with guaranteed false discovery rate control. Furthermore, it can (1) prioritize causal variants over associations due to linkage disequilibrium thereby improving interpretability; (2) help distinguish the signal due to rare variants from shadow effects of significant common variants nearby; (3) integrate multiple knockoffs for improved power, stability and reproducibility; and (4) flexibly incorporate state-of-the-art and future association tests to achieve the benefits proposed here. In applications to whole-genome sequencing data from the Alzheimer’s Disease Sequencing Project (ADSP) and COPDGene samples from NHLBI Trans-Omics for Precision Medicine (TOPMed) Program we show that our method compared with conventional association tests can lead to substantially more discoveries, including several new ones and many previously implicated in GWAS studies on Alzheimer’s Disease and lung function phenotypes with much larger sample sizes.&lt;/p&gt;</description>
    </item>
    
    <item>
      <title>2021 ASA Conference on Statistical Practice</title>
      <link>https://master--youthful-lamport-190a0e.netlify.app/conference/20210217csp/</link>
      <pubDate>Wed, 17 Feb 2021 00:00:00 +0000</pubDate>
      <guid>https://master--youthful-lamport-190a0e.netlify.app/conference/20210217csp/</guid>
      <description>&lt;p&gt;The goal of the conference is to provide participants with opportunities to learn new statistical methodologies and best practices in statistical analysis, design, consulting, and statistical programming.&lt;br&gt;
&lt;span style=&#34;color: salmon;&#34;&gt;&lt;em&gt;Early registration Deadline: Jan 11, 2021&lt;/em&gt;&lt;/span&gt;&lt;/p&gt;</description>
    </item>
    
    <item>
      <title>2020 New England Rare Disease Statistics (NERDS) Webinar Series</title>
      <link>https://master--youthful-lamport-190a0e.netlify.app/webinar/202011022020-new-england-rare-disease-statistics-nerds-webinar-series/</link>
      <pubDate>Mon, 02 Nov 2020 00:00:00 +0000</pubDate>
      <guid>https://master--youthful-lamport-190a0e.netlify.app/webinar/202011022020-new-england-rare-disease-statistics-nerds-webinar-series/</guid>
      <description>&lt;p&gt;&lt;strong&gt;1. Introductory NERDS Session&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;
&lt;p&gt;How to Select Endpoints and Quantify Treatment Effect in a Comparative Clinical Study on COVID-19 Diseases (L.J. Wei (Harvard))&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;Borrowing Information from Historical Data: A Double-edged Sword (Ying Yuan (MD Anderson))&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;&lt;a href=&#34;https://pfizerevents.webex.com/pfizerevents/lsr.php?RCID=13985dd6a939e0e4f8998620b4a428b1&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Recording&lt;/a&gt; (Password: hWFURkY5)&lt;/p&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;2. CID Program Update&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;A Bayesian Adaptive Trial in Duchenne Muscular Dystrophy (Steve Lake (Wave Life Sciences))&lt;/li&gt;
&lt;li&gt;Innovative Designs in the Rare Disease Setting (Dionne Price (FDA))&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://pfizerevents.webex.com/pfizerevents/lsr.php?RCID=1bc6e1d02b1002d62c170a17473e3d54&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Recording&lt;/a&gt; (Password: pMbpsJT7)&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;3. Gene Therapy in Rare Disease Development&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Gene Therapy: Opportunities and Challenges for the Treatment of Hemophilia (Michelle Casey (Pfizer))&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://pfizerevents.webex.com/pfizerevents/lsr.php?RCID=ccaaeefdd89e63e72892e9650397f117&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Recording&lt;/a&gt; (Password: NERDS456)&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;4. Case Studies in Rare Disease Drug Development&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Lessons from Notable New Drug Application involving External Controls (Margaret (Meg) Gamalo (Pfizer))&lt;/li&gt;
&lt;li&gt;Design and Analysis of Drop the Losers Studies in the Rare Disease Setting (Glen Laird (Vertex))&lt;/li&gt;
&lt;li&gt;A Case Study Using Nature History Data to Understand Long Term Disease Progression (Cindy Lu (Biogen))&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://pfizerevents.webex.com/pfizerevents/lsr.php?RCID=e227bbfd8699459593dffc5ce07cd795&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Recording&lt;/a&gt; (Password: Pq8pBWgU)&lt;/li&gt;
&lt;/ul&gt;</description>
    </item>
    
    <item>
      <title>Statistical Optimization Methods for Machine Learning</title>
      <link>https://master--youthful-lamport-190a0e.netlify.app/webinar/20200915statistical-optimization-methods-for-machine-learning/</link>
      <pubDate>Tue, 15 Sep 2020 12:00:00 -0800</pubDate>
      <guid>https://master--youthful-lamport-190a0e.netlify.app/webinar/20200915statistical-optimization-methods-for-machine-learning/</guid>
      <description>&lt;p&gt;Statistics and optimization are two of the foundational pillars of machine learning, and it is well recognized that optimization provides powerful tools for statistics. In recent years, techniques of the complementary nature, i.e., using statistics to improve optimization algorithms, have become increasingly successful. In this talk, we present several recent works on such statistical optimization methods. First, we discuss how to use statistical hypothesis testing to automatically adjust the learning rate of stochastic gradient methods in training deep neural networks. Then we overview some recent advances in structured nonconvex optimization using stochastic variance reduction techniques. Finally we will briefly explain how to leverage statistical preconditioning to accelerate distributed optimization.&lt;/p&gt;</description>
    </item>
    
    <item>
      <title>COVID-19: Pandemic Preparedness and Lessons Learned</title>
      <link>https://master--youthful-lamport-190a0e.netlify.app/webinar/20200610dia/</link>
      <pubDate>Wed, 10 Jun 2020 00:00:00 +0000</pubDate>
      <guid>https://master--youthful-lamport-190a0e.netlify.app/webinar/20200610dia/</guid>
      <description>&lt;ul&gt;
&lt;li&gt;An overview of how COVID-19 progressed&lt;/li&gt;
&lt;li&gt;How can pharmaceutical companies be better prepared? Should there be plans and clinical development strategies in place?&lt;/li&gt;
&lt;li&gt;How do we build resiliency? What steps could/should be implemented at various stages to ‘flatten the curve’?&lt;/li&gt;
&lt;li&gt;Vulnerable communities and minority populations are at a disadvantage. How do we address these health disparities?&lt;/li&gt;
&lt;/ul&gt;</description>
    </item>
    
  </channel>
</rss>
